Uromitexan

Uromitexan

mesna

Manufacturer:

Baxter Healthcare

Distributor:

Baxter Healthcare
/
Firma Chun Cheong
Concise Prescribing Info
Contents
Mesna
Indications/Uses
Prevention of urothelial toxicity due to oxazaphosphorines.
Dosage/Direction for Use
Adult 20% of oxazaphosphorine dose at time 0 (time of oxazaphosphorine inj) & then at 4 & 8 hr IV.
Special Precautions
Hypersensitivity reactions in patients w/ autoimmune disorders. Protective effect applies only to the urinary tract. Pregnancy & lactation.
Adverse Reactions
Hypersensitivity & inj reactions, GI effects, headache, pain in limb, decrease BP, tachycardia, skin reactions, exhaustion & weakness.
Drug Interactions
Incompatible w/ cisplatin, carboplatin, nitrogen mustard.
ATC Classification
V03AF01 - mesna ; Belongs to the class of detoxifying agents used in antineoplastic treatment.
Presentation/Packing
Form
Uromitexan inj 100 mg/mL
Packing/Price
4 mL x 15 × 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in